Degradable haemostat composition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10933160
APP PUB NO 20160106882A1
SERIAL NO

14894475

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In one aspect, the present invention includes a haemostat composition that has been washed with an alkali solution to reduce the presence of endotoxins, and which is able to safely gradually and fully degrade in a human or animal body within about 30 days and so can be utilised by physicians to stem a flow of blood and promote healing both after as well as during surgical procedures.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDTRADE PRODUCTS LIMITEDCREWE CHESHIRE CW1 6GL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gladman, June Warrington, GB 10 1
Hardy, Craig Cardigan, GB 32 133
Hoggarth, Andrew Crewe, GB 29 79

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 2, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 2, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00